Philip Morris (PM) stock has surged since Jan 2024 on Zyn nicotine pouch growth. PM now trades at a fair value. Read here for a detailed analysis.

Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...